Rajasthan govt set to revive Rajasthan Drugs and Pharma

Jaipur:  The government of Rajasthan is set to revive Rajasthan Drugs and Pharmaceuticals Limited (RDPL), a Central Public Sector Undertaking (CPSU) based in the state. RDPL is jointly owned by the Central government, which holds a 51% equity stake, and the Rajasthan state government, which owns the remaining 49%.

The decision to revive RDPL was announced earlier in the budget, and the Department of Medical and Health has begun follow-up measures. As part of this effort, Neha Giri, Managing Director of Rajasthan Medical Services Corporation Limited (RMSCL), recently conducted an inspection of the RDPL.

During the inspection, Giri was accompanied by RDPL’s Special Officer and other officials of the corporation, as per UNI.

She inspected the production area, quality control, storage facilities, main building, and campus of RDPL. She was informed that RDPL is located in an industrial area with approximately 10 acres of land under its possession.

Giri inspected the machines and equipment installed at the RDPL campus and assessed their functionality. She directed the RDPL representative to provide information about the company’s building, equipment, and all liabilities. She also sought information about the pending court cases related to RDPL and gave the necessary instructions.

The MD directed that a report be prepared on the 2016 fire incident at RDPL, as well as a compilation of information about the board of directors, currently employed staff, financial provisions, and all liabilities. She also inspected the water supply, electricity supply, biomedical waste, and designated storage areas within the RDPL campus.

Related Posts

CDSCO warns against sales of unauthorised toxic cosmetics products from Pakistan

The Central Drugs Standard Control Organisation (CDSCO) has issued a warning against sales and distribution of two unauthorised cosmetics products with excessive heavy metals labelled as “Made in Pakistan.” The…

Large stock of counterfeit medicines seized from private facility in Bengaluru

Investigators suspect that low-cost rebranded medicines were purchased and sold under different brand names. Expired medicines were allegedly collected, transferred into new containers and repackaged using counterfeit labels and packaging…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CDSCO warns against sales of unauthorised toxic cosmetics products from Pakistan

CDSCO warns against sales of unauthorised toxic cosmetics products from Pakistan

Large stock of counterfeit medicines seized from private facility in Bengaluru

Large stock of counterfeit medicines seized from private facility in Bengaluru

Punjab’s Drugs Challenge Shifts, Other States Blamed For Pharma Smuggling

Punjab’s Drugs Challenge Shifts, Other States Blamed For Pharma Smuggling

Spurious drug probe: SIT raids medical store in Bengaluru, detains proprietor

Spurious drug probe: SIT raids medical store in Bengaluru, detains proprietor

US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode